ZIM Laboratories Limited (ZIMLAB.BO)
INR 85.47
(-0.13%)
INR 85.47
(-0.13%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 172.46 Million INR | -29.42% |
| 2022 | 244.34 Million INR | 67.93% |
| 2021 | 145.5 Million INR | 98.84% |
| 2020 | 73.17 Million INR | 121.97% |
| 2019 | 32.96 Million INR | -78.51% |
| 2018 | 153.41 Million INR | -19.72% |
| 2017 | 191.09 Million INR | 2.82% |
| 2016 | 185.86 Million INR | 264.61% |
| 2015 | 50.97 Million INR | 123.59% |
| 2014 | -216.07 Million INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 8.98 Million INR | -88.89% |
| 2023 Q2 | 41.49 Million INR | 1731.2% |
| 2023 FY | 172.46 Million INR | -29.42% |
| 2023 Q1 | 2.26 Million INR | -96.87% |
| 2023 Q3 | 47.84 Million INR | 15.31% |
| 2023 Q4 | 80.85 Million INR | 68.99% |
| 2022 Q4 | 72.36 Million INR | 9.63% |
| 2022 Q1 | 51.47 Million INR | -26.78% |
| 2022 Q2 | 54.49 Million INR | 5.86% |
| 2022 FY | 244.34 Million INR | 67.93% |
| 2022 Q3 | 66 Million INR | 21.12% |
| 2021 Q4 | 70.3 Million INR | 72.62% |
| 2021 FY | 145.5 Million INR | 98.84% |
| 2021 Q1 | 1.88 Million INR | -87.82% |
| 2021 Q3 | 40.72 Million INR | 24.98% |
| 2021 Q2 | 32.58 Million INR | 1626.97% |
| 2020 Q2 | 11.94 Million INR | -63.58% |
| 2020 Q3 | 12.92 Million INR | 8.15% |
| 2020 FY | 73.17 Million INR | 121.97% |
| 2020 Q4 | 15.49 Million INR | 19.93% |
| 2020 Q1 | 32.8 Million INR | 42.83% |
| 2019 Q1 | 865 Thousand INR | -96.24% |
| 2019 Q2 | -6.08 Million INR | -803.82% |
| 2019 FY | 32.96 Million INR | -78.51% |
| 2019 Q4 | 22.97 Million INR | 50.93% |
| 2019 Q3 | 15.21 Million INR | 349.98% |
| 2018 Q4 | 23.02 Million INR | -60.91% |
| 2018 Q2 | 33.54 Million INR | -11.61% |
| 2018 Q1 | 37.94 Million INR | -51.3% |
| 2018 FY | 153.41 Million INR | -19.72% |
| 2018 Q3 | 58.9 Million INR | 75.64% |
| 2017 Q4 | 77.91 Million INR | 23.85% |
| 2017 Q3 | 62.91 Million INR | 117.8% |
| 2017 Q1 | 21.38 Million INR | 0.0% |
| 2017 Q2 | 28.88 Million INR | 35.05% |
| 2017 FY | 191.09 Million INR | 2.82% |
| 2016 FY | 185.86 Million INR | 264.61% |
| 2015 FY | 50.97 Million INR | 123.59% |
| 2014 FY | -216.07 Million INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 6.15 Billion INR | 97.199% |
| Aurobindo Pharma Limited | 31.72 Billion INR | 99.456% |
| Glenmark Life Sciences Limited | 4.7 Billion INR | 96.337% |
| Granules India Limited | 4.05 Billion INR | 95.745% |
| Indoco Remedies Limited | 984.6 Million INR | 82.484% |
| Achyut Healthcare Limited | 5.73 Million INR | -2908.793% |
| Ajanta Pharma Limited | 8.16 Billion INR | 97.887% |
| Alkem Laboratories Limited | 17.95 Billion INR | 99.04% |
| Alpa Laboratories Limited | 167.76 Million INR | -2.801% |
| Brooks Laboratories Limited | -195.91 Million INR | 188.028% |
| AstraZeneca Pharma India Limited | 1.61 Billion INR | 89.322% |
| Bajaj HealthCare Limited | -837.93 Million INR | 120.582% |
| Bliss GVS Pharma Limited | 754.54 Million INR | 77.143% |
| Dr. Reddy's Laboratories Limited | 55.68 Billion INR | 99.69% |
| Eris Lifesciences Limited | 3.91 Billion INR | 95.6% |
| FDC Limited | 3.05 Billion INR | 94.35% |
| Glenmark Pharmaceuticals Limited | -15.01 Billion INR | 101.148% |
| Gufic Biosciences Limited | 861.35 Million INR | 79.978% |
| Ind-Swift Laboratories Limited | 4.2 Billion INR | 95.903% |
| Ipca Laboratories Limited | 5.47 Billion INR | 96.849% |
| Jagsonpal Pharmaceuticals Limited | 224.63 Million INR | 23.223% |
| Krebs Biochemicals & Industries Limited | -197.28 Million INR | 187.419% |
| Lasa Supergenerics Limited | -217.3 Million INR | 179.365% |
| Laurus Labs Limited | 1.6 Billion INR | 89.258% |
| Lupin Limited | 19.14 Billion INR | 99.099% |
| Mankind Pharma Limited | 19.12 Billion INR | 99.098% |
| Medicamen Biotech Limited | 109.31 Million INR | -57.775% |
| Medico Remedies Limited | 82.9 Million INR | -108.016% |
| Megasoft Limited | -127.46 Million INR | 235.302% |
| NATCO Pharma Limited | 13.88 Billion INR | 98.758% |
| Piramal Pharma Limited | 178.2 Million INR | 3.219% |
| RPG Life Sciences Limited | 876.6 Million INR | 80.326% |
| Sigachi Industries Limited | 571.8 Million INR | 69.839% |
| Sun Pharmaceutical Industries Limited | 95.76 Billion INR | 99.82% |
| Suven Pharmaceuticals Limited | 3 Billion INR | 94.257% |
| Syncom Formulations (India) Limited | 253.14 Million INR | 31.871% |
| Unichem Laboratories Limited | -704.74 Million INR | 124.472% |
| Wanbury Limited | 559.56 Million INR | 69.179% |
| Windlas Biotech Limited | 581.87 Million INR | 70.36% |
| Zydus Lifesciences Limited | 38.59 Billion INR | 99.553% |
| Sun Pharma Advanced Research Company Limited | -3.87 Billion INR | 104.454% |
| Divi's Laboratories Limited | 16 Billion INR | 98.922% |
| Hester Biosciences Limited | 188.89 Million INR | 8.696% |
| Procter & Gamble Health Limited | 2 Billion INR | 91.419% |
| Amrutanjan Health Care Limited | 449.72 Million INR | 61.651% |
| Bal Pharma Limited | 73.92 Million INR | -133.305% |
| Strides Pharma Science Limited | -706.14 Million INR | 124.423% |
| Venus Remedies Limited | 284.9 Million INR | 39.467% |
| Aarti Pharmalabs Limited | 2.16 Billion INR | 92.049% |
| Nectar Lifesciences Limited | 49.95 Million INR | -245.273% |
| Shilpa Medicare Limited | 318.74 Million INR | 45.892% |
| Aarti Drugs Limited | 1.71 Billion INR | 89.939% |
| IOL Chemicals and Pharmaceuticals Limited | 1.34 Billion INR | 87.171% |
| Suven Life Sciences Limited | -1.05 Billion INR | 116.413% |
| Ind-Swift Limited | 142.31 Million INR | -21.186% |
| Valiant Laboratories Limited | 3.19 Million INR | -5296.245% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.52 Billion INR | 96.879% |
| Solara Active Pharma Sciences Limited | -5.67 Billion INR | 103.04% |
| Themis Medicare Limited | 435.23 Million INR | 60.375% |
| Hikal Limited | 696.02 Million INR | 75.221% |
| Torrent Pharmaceuticals Limited | 16.56 Billion INR | 98.959% |
| Sequent Scientific Limited | -358.69 Million INR | 148.082% |
| Novartis India Limited | 851.9 Million INR | 79.755% |
| Wockhardt Limited | -4.63 Billion INR | 103.725% |
| Jubilant Pharmova Limited | 771 Million INR | 77.631% |
| Biofil Chemicals and Pharmaceuticals Limited | 7.09 Million INR | -2331.81% |
| Neuland Laboratories Limited | 3 Billion INR | 94.253% |
| Morepen Laboratories Limited | 961.59 Million INR | 82.065% |
| Kilitch Drugs (India) Limited | 146.01 Million INR | -18.115% |
| Mangalam Drugs & Organics Limited | -90.71 Million INR | 290.112% |